糖尿病血管病变的药物治疗进展(4)

15时乐，黎蕾.糖尿病血管并发症线粒体氧化损伤机制及药物治疗进展[J].中华老年医学杂志，2006, 25(3): 229-230.

16Sugawara R，Hikichi T，Kitaya N，et al．Peroxynitrite decomposition catalyst，FP15，and poly (ADP?ribose) polymerase inhibitor，PJ34，inhibit leukocyte entrapment in the retinalmicrocircu1ation of diabetic rats[J]．Curr Eye Res，2004, 29: 11-16.

17 Zheng L,Szabo C,Kern TS. Poly (ADP?ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor?kappa B[J]. Diabetes，2004, 53: 2960-2967.

18 Pacher P，Liaudet L，Soriano FG, et al．The role of poly (ADP?ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes[J]．Diabetes，2002, 51: 514-521.

19 Xiao CY，Chen M，Zsengeller Z，et al. Poly(ADP?ribose) polymerase contributes to the de?velopment of myocardial infarction in diabetic rats and regulates the nuclear translocation of apoptosis?inducing factor[J]. J Pharmacol Exp Ther, 2004,10: 498-504.

20 Obrosova IG，Minchenko AG，Frank RN，et al．Poly (ADP?ribose) polymerase inhibitors counteract diabetes and hypoxia?induced retinal vascular endothelial growth factor overexpr? ession[J]. Int J Mol Med，2004, 14: 55-64.

21 Yokota T，Ma RC，Park JY，et al．Role of protein kinase C on the expression of platelet?derived growth factor and endothelin?1 in the retina of diabetic rats and cultured retinal capillary pencytes[J] . Diabetes, 2003, 52: 838-845.

22 Poulaki V，Qin W，Joussen AM，et al．Acute intensive insulin therapy exacerbates diabetic blood?retinal barrier breakdown via hypoxia?inducible factor?1 and VEGF[J]．J Clin Invest，2002, 109: 805 -815.

23 刘声远.糖尿病血管病变机制与防制进展[J].微循环杂志,2006, 16(4): 3-6.